M. P. Curtis et al. / Tetrahedron Letters 50 (2009) 5479–5481
5481
0.77 mmol) in acetonitrile (2 mL) was added 4-chlorobenzyl bro-
mide (53 mg, 0.26 mmol). The reaction mixture was heated at
80 °C for 2 h. Pd(PPh3)4 (15 mg, 0.013 mmol), 2-chloropyridine
3. Experimental
3.1. Typical experimental procedure for preparation and Suzuki
coupling of 7
(25 lL, 0.27 mmol), and 50 lL water were added. The reaction mix-
ture was stirred at 80 °C for 18 h. After cooling to room tempera-
ture, the mixture was filtered through Celite and concentrated.
Purification by flash chromatography eluting with a 0–50% EtOAc
in heptane gradient gave 1s (25 mg, 36%) as a colorless solid. 1H
NMR (CDCl3, 400 MHz) d 5.34 (s, 2H) 6.89 (d, J = 2.35 Hz, 1H)
7.15–7.21 (m, 3H) 7.27–7.33 (m, 2H) 7.39 (d, J = 2.35 Hz, 1H)
7.69 (m, 1H) 7.86–7.96 (m, 1H) 8.58–8.65 (m, 1H); m/z (CI) 270
([M+H]+, 100%).
To a solution of 3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-
yl)-1H-pyrazole(1.0 g, 5.1 mmol)in acetonitrile (35 mL)were added
3-(trifluoromethyl)benzyl bromide (1.23 g, 5.2 mmol) and cesium
carbonate (2.5 g, 7.7 mmol). The reaction mixture was heated at
80 °C for 2 h. The reaction mixture was cooled, filtered, and concen-
trated to provide 7 as a yellow solid. To a solution of crude 7 (125 mg,
0.36 mmol) in toluene/iPrOH/water (7 mL) were added 2-chloro-
benzothiazole (61 mg, 0.36 mmol), Pd(PPh3)4 (21 mg, 0.018 mmol),
and sodium carbonate (95 mg, 0.9 mmol). The reaction mixture was
heated at 80 °C for 18 h. After cooling to room temperature, the mix-
ture was concentrated and purified using flash chromatography,
eluting from 10:90 EtOAc/heptane to 50:50 EtOAc/heptane afford-
ing 1o (65 mg, 51 %) as a colorless solid. 1H NMR (CDCl3, 400 MHz)
d 5.45 (s, 2H), 7.05 (d, J = 2.4 Hz, 1H), 7.37 (t, J = 7.2 Hz, 1H), 7.42–
7.50 (m, 4H), 7.54 (s, 1H), 7.58, (d, J = 4.0 Hz, 1H), 7.89 (d,
J = 8.0 Hz, 1H), 8.06 (d, J = 8.4, 1H); 13C NMR (CDCl3 100.51 MHz) d
56.13, 106.13, 121.89, 123.20, 124.66, 125.51, 126.44, 129.75,
131.23, 131.59, 134.60, 137.04, 147.30, 153.90, 161.97 ppm; m/z
(CI) 360 ([M+H]+, 100%); Anal. Calcd for C18H12F3N3S: C, 60.16; H,
3.37; N, 11.69. Found: C, 59.94; H, 3.04; N, 11.56.
References and notes
1. McLaughlin, M.; Marcantonio, K.; Chen, C.; Davies, I. W. J. Org. Chem. 2008, 73,
4309.
2. Primas, N.; Mahatsekake, C.; Bouillon, A.; Lancelot, J.-C.; Sopkovà-de Oliveira
Santos, J.; Lohier, J.-F.; Rault, S. Tetrahedron 2008, 64, 4596.
3. Wang, L.; Woods, K. W.; Li, Q.; Barr, K. J.; McCroskey, R. W.; Hannick, S. M.;
Gherke, L.; Credo, R. B.; Hui, Y.; Marsh, K.; Warner, R.; Lee, J. Y.; Zielinski-Mozng,
N.; Frost, D.; Rosenberg, S.; Sham, H. L. J. Med. Chem. 2002, 45, 1697.
4. Price, S.; Bordogna, W.; Bull, R. J.; Clark, D. E.; Crackett, P. H.; Dyke, H. J.; Gill, M.;
Harris, N. V.; Gorski, J.; Lloyd, J.; Lockey, P. M.; Mullett, J.; Roach, A. G.; Roussel,
F.; White, A. B. Bioorg. Med. Chem. Lett. 2007, 17, 370.
5. The benzylic protons for 1a = d 5.37 ppm and 6a = d 6.01 ppm; 1b = 5.40 ppm
and 6b = d 6.05 ppm; 1e = d 5.46 ppm; 1g = d 5.45 ppm; 1l = d 5.47 ppm.
6. (a) Patel, M.; Bacheler, L. T.; Rayner, M. M.; Cordova, B. C.; Klabe, R. M.; Erickson-
Viitanen, S.; Seitz, S. P. Bioorg. Med. Chem. Lett. 1998, 8, 823; (b) Pavlik, W.;
Kurzweil, E. M. J. Heterocycl. Chem. 1992, 29, 1357; (c) Balle, T.; Perregaard, J.;
Ramirez, M. T.; Larsen, A. K.; SØby, K. K.; Liljefors, T.; Andersen, K. J. Med. Chem.
2003, 46, 265.
3.2. Typical experimental procedure for the one-pot
benzylation/Suzuki coupling of 2
7. (a) Campeau, L.; Fagnou, K. Chem. Soc. Rev. 2007, 36, 1058; (b) Tyrrell, E.;
Brookes, P. Synthesis 2003, 469.
To a suspension of 3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-
2-yl)-1H-pyrazole (50 mg, 0.26 mmol) and Cs2CO3 (273 mg,